The United States will send a “strike team” between ministries to help fight the massive surge of Indian authorities, along with a large influx of vaccine manufacturing materials, oxygen generators, and medicines. COVID-19 An incident that overwhelmed the national medical system and starved the oxygen gasping citizens.
The team will consist of staff from the Centers for Disease Control and Prevention (CDC) and the United States Agency for International Development, according to senior Biden administration officials who explained the plan to reporters on Monday afternoon. In this effort, “public health experts worked closely with the embassy and IndiaWith the Ministry of Health and experts, and the staff of the Epidemic Intelligence Service in India. “
Members of the team “work with Indian experts in many areas,” officials said. “Testing services, surveillance and epidemiology, bioinformatics-disease sequencing and modeling-including infection prevention and control. Vaccine deployment and risk communication.”
In addition, government officials have diverted the U.S. to ship raw materials and equipment for the production of AstraZeneca’s CovidShield vaccine, which has not yet been approved for use by U.S. health authorities, and has made oxygen generators and other equipment U.S. Announced that it will be provided with the kindness of. Ministry of Defense.
“We are also exploring options to provide oxygen levels and ventilators. We have technical discussions with India to ensure that the equipment we provide is connected to Indian devices. We do, and we plan to provide training related to everything. These requests as needed, “said Washington, providing New Delhi with” treatment, personal protective equipment, testing, “food and He added that it would support the transportation of other goods.
The announcement of such a large influx of aid into India came just hours after the president. Joe Biden Talking to India’s Prime Minister Narendra Modi, White House National Security Adviser Jake Sullivan told India’s counterparts that the United States is “decided to help India when needed.” next day.
According to an explanation of the conversation between the two White House leaders, Mr. Biden said, “[committed] The United States and India will work closely together in the fight against Covid-19, “he said,” promising solid support from the United States to the Indian people affected by the recent surge in Covid-19 cases. “
Indian officials say Biden is a vaccine production supplier that exports the raw materials needed to India by using the Defense Production Act, a Korean War-era law that allows the president to order the prioritization of government contracts by US companies. He complains that he is hindering his ability. However, White House officials responsible for coordinating the supply of supplies to fight the Covid-19 pandemic have pushed back the idea that there were all sorts of export bans imposed by the Biden administration.
In a series of tweets posted to his personal Twitter account, Whitehouse Covid-19 Supply Coordinator Tim Manning said that a company supplying US vaccine makers “exported products worldwide. I have. ” He also prioritized US government contacts by vaccine material suppliers. [supply] Because “more global manufacturing is done around the world than our suppliers can support.”
Biden administration officials also emphasized that supply shortages are a global problem and that the United States is “only one of many clients in the consumption of raw materials” for vaccine production, but the United States has called AstraZeneca. Vaccines that say they can give up supply for production will not be needed in the Biden administration’s vaccination efforts over the next few months.
“We will provide the AstraZeneca Cobishield Vaccine manufacturing material to the Serum Institute in India. We are diverting orders to India in the United States due to insufficient supply throughout our global manufacturing efforts,” officials said. .. “Due to the scope of the current situation and the state of self-production here, this is the most effective and quick step that can be taken at this stage to provide extensive support.”
Officials are currently undergoing quality assurance tests to ensure that these doses that have cleared the manufacturing process are not problematic at the Baltimore, Maryland facility, so the AstraZeneca vaccine is currently in the United States. Reduced their effectiveness, adding that there is no ready-to-administer supply of. However, they suggested that the doses of AstraZeneca under review, and the doses still in production, may be ready for distribution to other countries in a relatively short order.
“We anticipate that there will be approximately 10 million doses that may be released in the following cases: [Food and Drug Administration] “We will get consent that may occur in the coming weeks,” officials said, “an estimated additional 50 million doses at various stages of production.”
“When it becomes available in the next two months, we expect the United States to share about 60 million doses of AstraZeneca with other countries,” they said.